Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer stemness activity against non-small-cell lung cancer.

European Journal of Medicinal Chemistry
Xin WangRong Xiang

Abstract

A series of novel, highly potent, selective CDK9 inhibitors with cancer stem cells (CSCs) inhibition activity were designed and synthesized for non-small-cell lung cancer (NSCLC) therapy. Structure-activity relationship analysis based on enzymatic and cellular activities led to the discovery of a promising inhibitor 21e. 21e potently inhibited CDK9 with IC50 value of 11 nM and suppressed the stemness properties of NSCLC effectively. It could decrease the stemness phenotypes of NSCLC cells, including tumor sphere formation, side-population and stemness markers abundance. 21e displayed good selectivity over the CDK family kinases and kinase profiling assay against 381 kinases. In addition, 21e inhibited cell proliferation, colony-formation, and cell cycle progression and induced apoptosis in NSCLC. In H1299 xenograft mouse model, a once-daily dose of compound 21e at 20 mg/kg significantly suppressed the tumor growth without obvious toxicity. Studies of mechanisms of action indicated that 21e efficiently inhibited CDK9 signaling pathway and stemness both in vitro and in vivo. Collectively, 21e as a novel CDK9 inhibitor with CSCs inhibition properties could be a promising agent for the treatment of NSCLC.

References

May 26, 1995·The Journal of Biological Chemistry·N F Marshall, D H Price
Apr 1, 1996·The Journal of Experimental Medicine·M A GoodellR C Mulligan
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geoffrey I Shapiro
Feb 2, 2006·Stem Cells·Grant A Challen, Melissa H Little
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Feb 25, 2009·Nature Reviews. Cancer·Marcos Malumbres, Mariano Barbacid
Apr 15, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yanyan LiDuxin Sun
Aug 18, 2010·Cell Cycle·Cristian MoiolaAdriana De Siervi
Oct 14, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Georgios KallifatidisIngrid Herr
Nov 23, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Ulrike K SchmerwitzRobert Fürst
Mar 31, 2011·Cellular and Molecular Life Sciences : CMLS·Myoung-Eun HanSae-Ock Oh
Apr 13, 2011·International Journal of Cancer. Journal International Du Cancer·Xiangrui LiuShudong Wang
Feb 9, 2012·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Burkhard GreveMartin Götte
Mar 13, 2012·Annual Review of Biochemistry·Qiang ZhouDavid H Price
Feb 8, 2013·European Journal of Nutrition·Anna PawlikAnna Herman-Antosiewicz
Apr 9, 2013·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Slavica StojnevTakanori Hattori
Jan 15, 2016·Cell Cycle·Fatima Morales, Antonio Giordano
May 14, 2016·Journal of Medicinal Chemistry·Yogesh A SonawaneAmarnath Natarajan
Jun 28, 2017·Bioorganic & Medicinal Chemistry Letters·Yongtao LiRong Xiang
Jul 25, 2017·Journal of Cell Communication and Signaling·Reza Bayat MokhtariHerman Yeger
Jan 9, 2018·Journal of Medicinal Chemistry·Qingxiang GuoRong Xiang
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 15, 2018·Cancer Letters·Huiwen Yan, Pengcheng Bu

❮ Previous
Next ❯

Citations

Mar 14, 2020·Expert Opinion on Pharmacotherapy·Angel QinGregory P Kalemkerian
Apr 17, 2020·Signal Transduction and Targeted Therapy·Kaiyuan DengPeiqing Sun
Oct 22, 2020·Cell Chemical Biology·André RichtersAngela N Koehler
Jul 25, 2020·European Journal of Medicinal Chemistry·Brilliant N MarakVed Prakash Singh
May 28, 2021·Frontiers in Oncology·Abel Tesfaye AnshaboHugo Albrecht
Jun 3, 2021·Cancers·Ranadip MandalKlaus Strebhardt
Sep 29, 2021·Biochemical Society Transactions·W Douglas Fairlie, Erinna F Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis